Fraud and misconduct in biomedical research

Cover......Page 1
Contents......Page 6
Contributors......Page 8
Preface to the third edition......Page 10
Preface to the second edition......Page 11
1: The concept of scientific dishonesty: ethics, value systems, and research......Page 16
2: Regulations on scientific misconduct: lessons from the US experience......Page 24
3: Pay cheques on a Saturday night: the changing politics and bureaucracy of research integrity in the United States......Page 43
4: Research misconduct 1974–1990: an imperfect history......Page 62
5: Counteracting research misconduct: a decade of British pharmaceutical industry action......Page 75
6: A pharmaceutical company’s approach to the threat of research fraud......Page 99
7: Role of the FDA, NIH, and other bodies in the United States Conducting at least one trial per year......Page 113
9: Scientific fraud and misconduct in Finland......Page 133
10: Experiences of fraud and misconduct in healthcare research in Norway......Page 141
11: Dealing with misconduct in science: German efforts......Page 147
12: Fraud and misconduct in medical research in France......Page 159
13: The role of research ethics committees......Page 177
14: Statistical aspects of the detection of fraud......Page 187
15: Whistleblower......Page 206
16: Research fraud/ misconduct: a glance at the human side......Page 215
17: Fraud and misconduct in medical research: prevention......Page 224
18: Research misconduct: an editor’s view......Page 240
Appendix: Standard operating procedure (SOP) for the handling of suspected fraud/ misconduct......Page 253
Index......Page 257